Traws Pharma Inc. (TRAW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Traws Pharma Inc.

NASDAQ: TRAW · Real-Time Price · USD
2.25
0.43 (23.63%)
At close: Oct 03, 2025, 3:59 PM
2.24
-0.46%
After-hours: Oct 03, 2025, 07:54 PM EDT

Traws Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.9M 227K 226K 226K 226K 226K 226K 226K 226K 226K 226K 226K 226K 226K 226K 227K 236K 235K
Cost of Revenue
6K 9K 12K 14K 17K 17K 16K 16K 14K 14K 14K 14K 11K 7K 4K n/a n/a n/a
Gross Profit
2.9M 218K 214K 212K 209K 209K 210K 210K 212K 212K 212K 212K 158K 105K 52K n/a n/a n/a
Operating Income
-44.7M -49.34M -49.35M -24.09M -20.65M -19.37M -20.3M -21.57M -22.12M -21.63M -19.63M -17.66M -16M -16.53M -16.5M -18.99M -21.27M -23.97M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-17.82M -140.05M -166.52M -140.78M -137.05M -18.16M -18.95M -20.18M -20.84M -20.62M -18.96M -17.31M -15.36M -15.57M -16.16M -18.82M -21.61M -24.78M
Net Income
87.62M -34.61M -54.67M -140.78M -137.05M -18.16M -18.95M -20.18M -20.84M -20.62M -18.96M -17.31M -15.36M -15.57M -16.16M -18.83M -21.62M -24.78M
Selling & General & Admin
11.4M 11.69M 12.29M 10.89M 10.09M 10.33M 9.09M 9.02M 8.45M 8.37M 8.45M 8.5M 8.68M 9.39M 9.42M 9.13M 8.99M 8.73M
Research & Development
11.76M 13.43M 12.84M 13.41M 10.76M 9.25M 11.42M 12.76M 13.89M 13.47M 11.39M 9.36M 7.53M 7.35M 7.28M 10.07M 12.5M 15.45M
Other Expenses
24.44M 24.44M 24.44M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
47.6M 49.56M 49.56M 24.31M 20.86M 19.58M 20.51M 21.78M 22.33M 21.84M 19.84M 17.87M 16.22M 16.74M 16.71M 19.2M 21.49M 24.19M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
47.61M 49.57M 49.57M 24.32M 20.87M 19.6M 20.52M 21.8M 22.35M 21.86M 19.85M 17.88M 16.23M 16.76M 16.72M 19.21M 21.51M 24.2M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4K 4K 4K
Shares Outstanding (Basic)
5.82M 6.97M 3.65M 961.53K 1.01M 841.74K 840.14K 840.12K 839.19K 838.41K 837.04K 836.62K 836.16K 836.16K 835.82K 639.17K 631.23K 584.64K
Shares Outstanding (Diluted)
5.82M 7.22M 3.65M 961.53K 1.01M 841.74K 840.14K 840.12K 839.19K 838.41K 837.04K 836.62K 836.16K 836.16K 835.82K 639.17K 631.23K 584.64K
EPS (Basic)
15.69 -105.83 -113.92 -141.34 -138.17 -21.61 -22.57 -24.07 -24.88 -24.63 -22.67 -20.7 -19.65 -21.54 -24.67 -33.14 -40.67 -50.32
EPS (Diluted)
15.61 -105.91 -113.92 -141.34 -138.17 -21.61 -22.57 -24.07 -24.88 -24.63 -22.67 -20.7 -19.65 -21.54 -24.67 -33.14 -40.67 -50.32
EBITDA
-17.82M -140.04M -166.51M -140.77M -137.03M -18.14M -18.93M -20.17M -20.83M -20.6M -18.95M -17.29M -15.35M -15.56M -16.15M -18.81M -21.6M -24.76M
EBIT
-17.82M -140.05M -166.52M -140.78M -137.05M -18.16M -18.95M -20.18M -20.84M -20.62M -18.96M -17.31M -15.36M -15.57M -16.16M -18.82M -21.61M -24.78M
Depreciation & Amortization
6K 9K 12K 14K 17K 17K 16K 16K 14K 14K 14K 14K 14K 14K 14K 14K 15K 13K